Home›Articles›From accelerated approval to withdrawal: the short market life of UkoniqArticleFrom accelerated approval to withdrawal: the short market life of UkoniqArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnUmbralisib, Drugs and Medicinal Substances Well-attested SourcesUmbralisib (Wikipedia)Medical usesQuote, Medical usesThe decision was based on the overall survival (OS) data from the phase III trial, Unity-CLL, that illustrated and increasing imbalance in OS.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.